Obstetric Outcomes in Preeclamptic Pregnancies by Nice Risk Groups

Article Sidebar

PDF
Published: 23.04.2026

Main Article Content

F. Kussainova
«Asfendiyarov Kazakh National Medical University» NCJSC; Republic of Kazakhstan
A. Turlanova
«Asfendiyarov Kazakh National Medical University» NCJSC; Republic of Kazakhstan
D. Galeyeva
«Asfendiyarov Kazakh National Medical University» NCJSC; Republic of Kazakhstan
D. Akhriyeva
«Asfendiyarov Kazakh National Medical University» NCJSC; Republic of Kazakhstan
D. Kalymbetova
«Asfendiyarov Kazakh National Medical University» NCJSC; Republic of Kazakhstan

Abstract

Preeclampsia is one of the leading causes of maternal and perinatal morbidity and mortality, affecting 3–8% of pregnancies worldwide, including Kazakhstan. According to NICE guidelines, risk stratification can be performed based on maternal factors, including obstetric and medical history. However, the effectiveness of this approach is limited: its predictive value is approximately 41% for preeclampsia before 32 weeks of gestation, 39% before 37 weeks, and 34% at 37 weeks and beyond. Therefore, this study presents a retrospective analysis of pregnant women with preeclampsia stratified into risk groups based solely on maternal factors.

Downloads

Download data is not yet available.

Article Details

Issue

No. 292 (2026): 16th ISPC «Challenges in Science of Nowadays» (April 26-28, 2026; Washington, USA).

Section

Medicine and Pharmacy
Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

How to Cite

Kussainova, F., Turlanova, A., Galeyeva, D., Akhriyeva, D., & Kalymbetova, D. (2026). Obstetric Outcomes in Preeclamptic Pregnancies by Nice Risk Groups. InterConf. Scientific Collection, 292, 141-145. https://interconf.space/index.php/regular/article/view/47

References

Ma'ayeh M, Costantine MM. Prevention of preeclampsia. Semin Fetal Neonatal Med. 2020 Oct;25(5):101123. doi: 10.1016/j.siny.2020.101123. Epub 2020 Jun 2. PMID: 32513597; PMCID: PMC8236336.

Myatt L. The prediction of preeclampsia: the way forward. Am J Obstet Gynecol. 2022 Feb;226(2S): S1102-S1107.e8. doi: 10.1016/j.ajog.2020.10.047. Epub 2021 Mar 27. PMID: 33785181.

Dubrovina, Svetlana & Muzalchanova, Yu & Vasil'eva, V.. (2018). Early prediction of preeclampsia (a review). Problemy reproduktsii. 24. 67. 10.17116/repro201824367.

Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol. 2017;133(1):e1–25. [DOI] [PubMed] [Google Scholar

Tan, M.Y., Syngelaki, A., Poon, L.C., Rolnik, D.L., O'Gorman, N., Delgado, J.L., Akolekar, R., Konstantinidou, L., Tsavdaridou, M., Galeva, S., Ajdacka, U., Molina, F.S., Persico, N., Jani, J.C., Plasencia, W., Greco, E., Papaioannou, G., Wright, A., Wright, D. and Nicolaides, K.H. (2018), Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation. Ultrasound Obstet Gynecol, 52: 186-195.